Cytomegalovirus haemorrhagic colitis complicating COVID-19 in
an immunocompetent critically ill patient: a case
report
Running
title
Cytomegalovirus haemorrhagic colitis and COVID-19
Authors
Sophie Leemans1 (SL),
Evelyne Maillart1 (EM), Héloïse Van
Noten1 (HVN), Lucas Oliveira Dos
Santos2 (LODS), Laura Maria
Leahu3 (LML), Prochore Kamgang2(PK), Andrea Gallerani4 (AG), Philippe
Clevenbergh1(PC)
Authors
affiliations
1Department of Infectious Diseases,
Centre Hospitalier Universitaire
Brugmann, Brussels, Belgium
2Department of Internal Medicine, Centre Hospitalier
Universitaire Brugmann, Brussels, Belgium
3Department of Physical and Rehabilitation Medicine,
Centre Hospitalier Universitaire Brugmann, Brussels, Belgium
4Department of Intensive Care Medicine, Centre
Hospitalier Universitaire Brugmann, Brussels, Belgium
Authors
contributions
All authors have made substantial contributions in acquisition of data
and their interpretation.
SL wrote the draft, which was actively revised by PC, EM, HVN and PK.
Corresponding
author
Sophie Leemans MD
Department of Infectious Diseases
CHU Brugmann, Place Van Gehuchten 4, 1020 Brussels, Belgium
Tel.: +32 2 477 36 68
E-mail:sophie.leemans@chu-brugmann.be
ORCID ID: 0000-0001-7331-5159
Disclosure of
interest
The authors report no conflict of interest.
Funding
None.
Ethical
approval
The authors confirm that the patient signed an informed consent document
before the submission of this manuscript.
Cytomegalovirus haemorrhagic
colitis complicating COVID-19 in an immunocompetent critically ill
patient
Leemans S, Maillart E, Van Noten H, Oliveira Dos Santos L, Leahu LM,
Kamgang P, Gallerani A and Clevenbergh P